88 Odcinki

  1. Tim Vanuytsel on spore-forming probiotics in functional dyspepsia

    Opublikowany: 9.09.2021
  2. Raymond Henderson on the economic burden of colorectal cancer

    Opublikowany: 12.08.2021
  3. Sigurður Ólafsson on eliminating hepatitis C in Iceland

    Opublikowany: 22.06.2021
  4. Caroline Ovadia on intrahepatic cholestasis of pregnancy

    Opublikowany: 3.06.2021
  5. Matthew Akiyama on hepatitis C in prisons

    Opublikowany: 12.04.2021
  6. Monika Sarkar on reproductive health in women with liver disease

    Opublikowany: 11.03.2021
  7. Colorectal cancer risk in patients with Crohn’s disease

    Opublikowany: 12.03.2020
  8. Liver damage in young adults

    Opublikowany: 17.01.2020
  9. Treatments for IBS

    Opublikowany: 14.01.2020
  10. Statins and decompensated cirrhosis

    Opublikowany: 27.11.2019
  11. Global burden of pancreatic cancer and colorectal cancer

    Opublikowany: 4.11.2019
  12. Paediatric inflammatory bowel disease

    Opublikowany: 12.09.2019
  13. Transplanting hepatitis C-infected hearts

    Opublikowany: 28.08.2019
  14. Primary anastomosis as a treatment for diverticulitis

    Opublikowany: 31.07.2019
  15. Faecal microbiota transplantation in IBS

    Opublikowany: 30.07.2019
  16. Treating faecal incontinence in women

    Opublikowany: 17.07.2019
  17. Viral hepatitis in children & adolescents

    Opublikowany: 23.05.2019
  18. Whole-body MRI: the STREAMLINE trials

    Opublikowany: 11.05.2019
  19. A new drug for short bowel syndrome

    Opublikowany: 5.04.2019
  20. Eosinophilic oesophagitis endotype classification

    Opublikowany: 9.03.2019

3 / 5

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

Visit the podcast's native language site